Neurology

Enrollment timelines measured in months, not weeks

Long screening timelines, cognitive assessments, and caregiver involvement make neurology trials uniquely challenging. TrialScreen sustains engagement over months and works seamlessly with caregivers through text-based communication.

See How It Works →
The Challenge

Why neurology trials take so long to fill

Neurology enrollment faces structural barriers that short-term outreach can't overcome.

Long Screening Timelines

Neurology trials often require weeks or months of sustained engagement before a participant is fully screened. Traditional outreach loses patients to drop-off long before eligibility is confirmed.

Cognitive Assessments and Caregiver Coordination

Many neurology patients rely on caregivers for communication and decision-making. Screening must accommodate both the patient and their caregiver, adding complexity to every interaction.

Low Enrollment for Rare Conditions

Neurological conditions like ALS, Huntington’s, and rare epilepsies have extremely small eligible populations. Every potential participant must be identified and engaged with precision.

The Solution

How TrialScreen sustains engagement

Sustained SMS Engagement

TrialScreen maintains ongoing text conversations over weeks and months. Participants reply on their schedule, and the AI picks up right where the last session ended without losing context.

Caregiver-Friendly Communication

Text-based screening works naturally for caregivers who manage communication on behalf of patients. Caregivers can respond at convenient times without scheduling phone calls around care routines.

Portfolio Matching Across Conditions

A participant screened for an Alzheimer’s trial who doesn’t qualify may match a Parkinson’s, MS, or epilepsy study in your portfolio. TrialScreen checks every active protocol in one interaction.

By the Numbers

The neurology enrollment reality

46%

of Phase III neurology trials launched without positive Phase II

Published systematic study

<4%

of US adults participate in clinical trials

NIH

80%

of trials fail to meet enrollment targets

JMIR, 2020

See how TrialScreen handles neurology protocols

Book a demo and we'll show you sustained SMS engagement and caregiver-friendly screening in action.